Literature DB >> 3577669

Sympathetic cholinergic dysfunction in amyotrophic lateral sclerosis.

S A Barron, J Mazliah, E Bental.   

Abstract

The results of evaluation of the autonomic nervous system of a patient with amyotrophic lateral sclerosis are presented. As previously reported, parasympathetic function and sympathetic adrenergic function were normal as assessed by cardiovascular reflexes. However, a disturbance in sympathetic cholinergic function as measured by the sympathetic skin response was demonstrated. We suggest that the latter test be included in all electrophysiological evaluations of autonomic function in amyotrophic lateral sclerosis.

Entities:  

Mesh:

Year:  1987        PMID: 3577669     DOI: 10.1111/j.1600-0404.1987.tb07890.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

1.  Alteration in autonomic function and cardiovascular regulation in amyotrophic lateral sclerosis.

Authors:  K Chida; S Sakamaki; T Takasu
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

2.  Emotional responding in amyotrophic lateral sclerosis.

Authors:  Dorothée Lulé; Anja Kurt; Reinhart Jürgens; Jan Kassubek; Volker Diekmann; Eduard Kraft; Nicola Neumann; Albert C Ludolph; Niels Birbaumer; Silke Anders
Journal:  J Neurol       Date:  2005-06-24       Impact factor: 4.849

3.  Autonomic dysfunction in patients with chronic intestinal pseudo-obstruction.

Authors:  M Camilleri; R K Balm; P A Low
Journal:  Clin Auton Res       Date:  1993-04       Impact factor: 4.435

Review 4.  Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer's Disease.

Authors:  Jose L Martinez; Matthew D Zammit; Nicole R West; Bradley T Christian; Anita Bhattacharyya
Journal:  Front Aging Neurosci       Date:  2021-07-12       Impact factor: 5.702

5.  Targeted demethylation of the SLC5A7 promotor inhibits colorectal cancer progression.

Authors:  Yang Li; Baike Liu; Xiaonan Yin; Zhiyuan Jiang; Chao Fang; Na Chen; Bo Zhang; Lei Dai; Yuan Yin
Journal:  Clin Epigenetics       Date:  2022-07-20       Impact factor: 7.259

Review 6.  Alzheimer's disease: Targeting the Cholinergic System.

Authors:  Talita H Ferreira-Vieira; Isabella M Guimaraes; Flavia R Silva; Fabiola M Ribeiro
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.